Peripheral Neuropathy Trial, Recruiting (NCT07233408)

Peripheral Neuropathy Trial, Recruiting NCT07233408 Sponsor: Massachusetts General Hospital Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07233408 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You currently live in the United States
You have been diagnosed with Neurofibromatosis 1 (NF1) by a doctor
You speak English
You have been identified as having low health literacy (difficulty reading or understanding health information) based on a standardized test
You have a routine check-up appointment with your primary care doctor (not an urgent or sick visit) scheduled within the next 3 months after agreeing to join the study

Who may not be able to join:

You are unwilling or unable to give your informed consent to participate in the study
You have a level of cognitive impairment that, in the opinion of the study investigator, would prevent you from completing study questionnaires (confirm with trial site)
You have already been enrolled in clinical trial NCT06262113, or you are the parent or guardian of someone who is enrolled in that trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Vanessa Merker, PhD, Massachusetts General Hospital

Phone: 617-724-5321

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07233408

Sponsor: Massachusetts General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 617-724-5321

More information: https://clinicaltrials.gov/study/NCT07233408

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You currently live in the United States
You have been diagnosed with Neurofibromatosis 1 (NF1) by a doctor
You speak English
You have been identified as having low health literacy (difficulty reading or understanding health information) based on a standardized test
You have a routine check-up appointment with your primary care doctor (not an urgent or sick visit) scheduled within the next 3 months after agreeing to join the study

Who may not be able to join:

You are unwilling or unable to give your informed consent to participate in the study
You have a level of cognitive impairment that, in the opinion of the study investigator, would prevent you from completing study questionnaires (confirm with trial site)
You have already been enrolled in clinical trial NCT06262113, or you are the parent or guardian of someone who is enrolled in that trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Massachusetts General Hospital

Registry

ClinicalTrials.gov

Start date

28 December 2025

Est. completion

30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Videos and NF1 Peer Navigator Use as an Addition to My NF Guide

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov